News

PhRMA's Washington wish list

May 21, 2012

PhRMA presented Washington with its legislative wish list - and a warning that plenty of other countries are trying to woo the industry away from the US.
 

Study: Young Latinas are key decision makers, prefer English

May 21, 2012

Effectively communicating health messages to the Hispanic community requires one key thing: reaching Latinas between the ages of 25 and 35.
 

Pharmas are from Mars, Payers are from Venus

May 17, 2012

Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost.
 

Goodbye Plavix, hello competition

May 17, 2012

Long-running blockbuster Plavix has joined the patent graveyard, and competitors are all in.
 

Indian conglomerate buys Manhattan Research parent for $635m

May 16, 2012

A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.
 

Sales forces shrank in 2011, but not everywhere

May 16, 2012

Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn't shared evenly between the biggest of pharmas, as a number of players scaled up.
 

National plan seeks Alzheimer's treatment by 2025

May 15, 2012

HHS Secretary Kathleen Sebelius released the National Plan to Address Alzheimer's Disease at the second day of the National Alzheimer's Research Summit Tuesday.
 

Coach vs. cancer in BMS-backed awareness effort

May 15, 2012

Former Steelers coach Bill Cowher is fronting a Bristol-Myers Squibb-backed Melanoma Exposed awareness campaign.
 

Wolters Kluwer deals health analytics unit to private equity firm

May 15, 2012

Symphony Technology Group, a private equity firm, acquired the healthcare analytics business of Wolters Kluwer, the companies said.
 

RX-to-OTC proposal gets mixed reviews

May 14, 2012

Industry and physician groups expressed wary support for the FDA's "new paradigm" drug proposal, which would create a nonprescription "Behind the Counter" class of drugs available through pharmacists.
 

Siding with Lilly, appeals court overturns decision in rep overtime case

May 10, 2012

The latest round of Sales Reps vs. Pharma has favored...the pharma industry. The Seventh Circuit Court of Appeals said that Eli Lilly did not owe former rep Susan Schaeffer-LaRose overtime.
 

Humira on solid ground, analysts say, despite vote on Pfizer hopeful

May 10, 2012

The general consensus surrounding the FDA advisory panel's 8-2 vote in favor of Pfizer's rheumatoid arthritis hopeful tofacitinib yesterday was that Abbott's Humira doesn't have to watch its back.
 

Makers of pain pills, advocacy groups at center of Senate probe

May 09, 2012

The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.
 

Saatchi shop rebrands to sharpen specialty focus

May 08, 2012

Saatchi & Saatchi Innovations, Publicis' Pennsylvania-based outpost servicing specialty pharma, is rebranding as Saatchi Science.
 

Docs trust ED drugs above all, go with their emotions when prescribing

May 08, 2012

Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.
 

Doximity goes back to school, creates alumni app

May 07, 2012

Physician social network Doximity announced Saturday that it is creating an app just for Stanford Medical School students and alumni. Co-founder Jeff Tangney said it's the first of several university groups.
 

Roche ends dalcetrapib trial, questions linger on CETP class

May 07, 2012

A treatment Roche called a longshot has been left in the dust, throwing the fate of CETP inhibition into doubt once again.
 

Nurses get their own app with Lippincott launch

May 07, 2012

As of Monday, nurses will be able to tap into the Nursing Drug Handbook with an app, a first for the 32-year-old publication.
 

CMS pulls plug on transparency deadline

May 04, 2012

The Centers for Medicare and Medicaid Services said manufacturers won't have to start collecting physician payment data until January 1, 2013.
 

Pfizer restructures comms, Kerins to depart this summer

May 03, 2012

Several communications staffers at Pfizer will exit the company in coming weeks as part of a restructuring effort, PRWeek reported.
 

Agency Spotlight

Click here for MM&M’s guide to Healthcare Agencies
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence Agency App Celebrity Conflict Of Interest Diabetes Digital Direct To Consumer (DTC) Downsize Education & Awareness FDA Government Health Plans HMOs Hospitals Insurers Law Marketing Research Mobile Obesity Oncology Payers PBMs Sales Force